Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10039946HBVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS10040735HBVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS20001818HPVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS20010059HPVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS44025444HTLV-1ENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS44016388HTLV-1ENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TCGA Plot Options
Drug Information
GeneSLC6A3
DrugBank IDDB03701
Drug NameVanoxerine
Target IDBE0000647
UniProt IDQ01959
Regulation Typeantagonist
PubMed IDs11249581; 18845198
CitationsPreti A: Vanoxerine National Institute on Drug Abuse. Curr Opin Investig Drugs. 2000 Oct;1(2):241-51.@@Stepanov V, Jarv J: Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909). Neurochem Int. 2008 Dec;53(6-8):370-3. doi: 10.1016/j.neuint.2008.09.005. Epub 2008 Sep 18.
GroupsInvestigational
Direct ClassificationDiphenylmethanes
SMILESFC1=CC=C(C=C1)C(OCCN1CCN(CCCC2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL281594